Health Canada has licensed
Stethophone®, a Canadian-developed, AI-powered app that allows
users to capture and analyze heart sounds using only a smartphone.
Designed for both healthcare professionals and personal use,
Stethophone helps detect structural and rhythmic heart anomalies at
the precise moment symptoms or concerns arise.
ST.
JOHN'S, Newfoundland, Nov. 5, 2024
/PRNewswire-PRWeb/ -- Health Canada has licensed Stethophone®, a
Canadian-developed, AI-powered app that allows users to capture and
analyze heart sounds using only a smartphone. Designed for both
healthcare professionals and personal use, Stethophone helps detect
structural and rhythmic heart anomalies at the precise moment
symptoms or concerns arise.
"Stethophone has achieved a big leap in
both medical accuracy and convenience over other professional-grade
devices, at a fraction of the cost," Dr. Yaroslav Shpak co-Founder and Chief Medical
Office.
Stethophone is classified as a regulated medical device, meaning
it must adhere to strict protocols for user protection, accurate
performance, and secure data handling. Health Canada approval signifies that Stethophone
meets these stringent standards delivering reliable, high-quality
insights into heart health, giving both users and healthcare
providers confidence in this groundbreaking technology.
"This authorization from Health Canada allows us to offer
Stethophone to every Canadian with a heart concern, whether for
themselves or someone in their care," said Mark Opauszky, CEO of
Sparrow BioAcoustics.
"Testing and validation involved thousands of patients,
supported by doctors from Canada
and the international cardiology community." Said Nadia Ivanova founder and Chief Product
Officer at Sparrow.
" Stethophone has achieved a big leap in both medical accuracy
and convenience over other professional-grade devices, at a
fraction of the cost," added Dr. Yaroslav
Shpak co-Founder and Chief Medical Officer. "Helping to
capture and identify symptoms at home goes a long way to ensuring
people are treated before conditions progress too far."
Stethophone is expected to launch within days, signalling
Canada's leadership in medical AI.
This landmark approval highlights the potential for mobile
technology to play a pivotal role in population-wide heart health,
providing Canadians and the world with a new, trusted tool for
heart sound analysis.
For more information about Stethophone and Sparrow BioAcoustics,
visit https://stethophone.com/.
About Sparrow BioAcoustics
Sparrow BioAcoustics, with offices in Newfoundland and Nova Scotia, is leading the Software as a
Medical Device industry in new directions for cardiac and pulmonary
disease detection. Their team of physicians, engineers and data
scientists are working to unlocking the richest sources of
diagnostic information about cardiac and pulmonary conditions for
the population. Their mission is to help the millions of people
at-risk and suffering from cardiac and respiratory disease to live
longer, healthier lives enabled by earlier detection and quicker
treatment.
Media Contact
Mark Opauszky, Mark Opauszky, 1
4162688966, mark@sparrowacoustics.com, sparrowbioacoutics.com
View original content to download
multimedia:https://www.prweb.com/releases/health-canada-licenses-landmark-canadian-stethophone-app-302296172.html
SOURCE Sparrow BioAcoustics